FreeStyle Libre wins Medicare coverage

On Thursday, Abbott Laboratories announced their FreeStyle Libre, a continuous glucose monitor, received Medicare coverage one month after it was launched. It is the first continuous glucose monitor on the market that does not require patients to prick their finger to draw blood.  Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply